Antilipolytic activity of a series of pyrazine-N-oxides was written by Ambrogi, Vittorio;Cozzi, Paolo;Sanjust, Paolo;Bertone, Leone;Paolo Lovisolo, Pier;Briatico Vangosa, Gabriella;Angelucci, Romano. And the article was included in European Journal of Medicinal Chemistry in 1980.Recommanded Product: 89323-09-1 This article mentions the following:
Of the 45 pyrazinecarboxamide 4-oxides I (R = H, Cl, alkyl, NH2, etc.; R1 = H, Et; R2 = H, OH, Et, etc.; or NR1,R2 = morpholino) and pyrazine 4-oxide carboxylic acids and esters II (R = H, Me, Cl, etc.; R1 = H, Me, Et, etc.) synthesized, 3 showed pronounced and lasting antilipolytic activity in rats. The 3 were: 5-methylpyrazine-2-carboxylic acid 4-oxide (II; R = 5-Me; R1 = H) [51037-30-0], 5-methylpyrazine-2-carboxylic acid diethylamide 4-oxide (I; R = 5-Me; R1 = R2 = Et) [51037-28-6], and allyl 5-methylpyrazine-2-carboxylate-4-oxide (II; R = 5-Me; R1 = CH2CH:CH2) [74416-40-3]. The presence of a Me group at position 5 in the mol. was indispensable for pharmacol. activity. Esterification of the carboxyl in position 2 or its substitution with a primary, secondary, or tertiary carboxamide group did not cause notable changes in activity. In the experiment, the researchers used many compounds, for example, 5-Aminopyrazine-2-carboxamide (cas: 89323-09-1Recommanded Product: 89323-09-1).
5-Aminopyrazine-2-carboxamide (cas: 89323-09-1) belongs to pyrazine derivatives. Pyrazinesare six-membered aromatic heterocyclic organic compounds with two nitrogen atoms at 1,4-positions. Pyrazine is a weaker base (pKb = 13.4) than pyridine (pKb = 8.8), pyrimidine (pKb = 12.7). Pyrazine-based skeletons were incorporated into agents targeting a range of ailments. Many derivatives were synthesized and evaluated as potential cancer treatments.Recommanded Product: 89323-09-1